
Biologics and Infection Risk: Time to Rethink Prevention?
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxOWXRreVBiQUFhVW5WMFVLYnFGczJ1Z0M1X2NVY25hdklfUzJhUTlMeUU1VTgxRDVKLXQzb2JfRnFUYVlra09Xcl80aXVvakQ0QzBMdnFxQ3hZQW1Bdzh3Sk5yd1Fsb1VGV0RpUjNPd0w2U2JnazV0VTN3UEozV0tpRng1YUxLRHFVNmtzYWo0VGFKS3pOVnp0ZGc4VVVTVnoyWS1hUw?oc=5" target="_blank">Biologics and Infection Risk: Time to Rethink Prevention?</a>&nbsp;&nbsp;<font color="#6f6f6f">Medscape</font>
